PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

359 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
181.
Devillier, P.* ; Zielen, S.* ; Heinrich, J. ; Richter, H.* & Wahn, U.*: A treatment with 300 index of reactivity (IR) 5-grass pollen tablet is associated with a reduction of asthma onset and a reduction of its progression. Allergy 72, 764-764 (2017)
182.
Fischer, J.* et al.: Prevalence of type I sensitization to alpha-gal in forest service employees and hunters: Is the blood type an overlooked risk factor in epidemiological studies of the alpha-Gal syndrome? Reply. Allergy 72, 2045-2047 (2017)
183.
Graessel, A. et al.: Interference into JAK/stat signalling-a concept for improved allergen-specific immunotherapy? Allergy 72, 40-40 (2017)
184.
Hammerl, P. ; Chaker, A. ; Prehn, C. ; Schmidt-Weber, C.B. & Esser-von Bieren, J.: Targeted metabolomics reveals novel lipid and amino acid metabolism alterations in aspirin-exacerbated respiratory disease. Allergy 72, 85-85 (2017)
185.
Häring, F. et al.: Towards automatic, real-time pollen monitoring for allergic patients: Need for health information services? Allergy 72, 80-81 (2017)
186.
Heinrich, J. ; Zielen, S.* ; Wahn, U.* ; Richter, H.* & Devillier, P.*: Treatment with grass pollen slit tablets is associated with long-term relief of allergic rhinitis: A retrospective real-life dataset analysis. Allergy 72, 375-375 (2017)
187.
Jatzlauk, G.* ; Bartel, S.* ; Heine, H.* ; Schloter, M. & Krauss-Etschmann, S.*: Influences of environmental bacteria and their metabolites on allergies, asthma and host microbiota. Allergy 72, 1859-1867 (2017)
188.
Keller, T.* et al.: Sex-shift of respiratory multimorbidity prevalence during adolescence - pooled analyses of longitudinal european birth cohort data from medall. Allergy 72, 72-73 (2017)
189.
Lambert, K.A.* et al.: Residential greenness and allergic respiratory disease in children and adolescents: A systematic review and meta-analysis. Allergy 72, 425-425 (2017)
190.
Markevych, I. ; Standl, M. ; Lehmann, I.* ; von Berg, A.* & Heinrich, J.: Food diversity during first year of life and allergic diseases until 15 years: Results from lisaplus birth cohort. Allergy 72, 63-63 (2017)
191.
Milger, K. et al.: Identification of a plasma miRNA biomarker-signature for allergic asthma: A translational approach. Allergy 72, 1962-1971 (2017)
192.
Mueller-Rompa, S.E.* ; Markevych, I. ; Heinrich, J. ; Von Mutius, E.* & Ege, M.J.*: Environmental exposures, farming and asthma in childhood. Allergy 72, 363-363 (2017)
193.
Pfaar, O.* et al.: Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper. Allergy 72, 713-722 (2017)
194.
Pfaar, O.* et al.: Perspectives in allergen immunotherapy: 2017 and beyond. Allergy 73, 5-23 (2017)
195.
Roberts, G.* et al.: EAACI guidelines on allergen immunotherapy: Allergic rhinoconjunctivitis. Allergy 73, 765-798 (2017)
196.
Russkamp, D. et al.: Component-resolved allergen content of therapeutic honeybee venom extracts. Allergy 72, 18-18 (2017)
197.
Schiener, M. et al.: Polistes venom allergy: Identification and immunological characterization of novel allergens. Allergy 72, 17-18 (2017)
198.
Schlumprecht, C. et al.: Immuno-modulatory effects of prebiotics, probiotics and active microbial structures on human primary epithelial cells. Allergy 72, 45-45 (2017)
199.
Shamji, M.H.* et al.: Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: An EAACI Position Paper. Allergy 72, 1156-1173 (2017)
200.
Standl, M. et al.: Association of atopic dermatitis with cardiovascular risk factors and diseases. Allergy 72, 53-53 (2017)